October is Breast Cancer Awareness Month
According to the National Breast Cancer Foundation, this year an estimated 276,480 new cases of invasive breast cancer as well as 48,530 new cases of non-invasive breast cancer will be diagnosed in women in the United States. An estimated 42,170 women will die from breast cancer in 2020.
Early detection, better screening, increased awareness and improving treatment options are our best defenses and must not be neglected during the pandemic.
Science based and data driven research on the potential benefits of cannabinoids in breast cancer therapy is underway. Cannabidiol’s potential to help inhibit the Id-1 gene whose primary function induces the growth of cancer cells in the breast is being studied. Due to decades of marijuana prohibition cannabis research and medicine is a relatively new and growing sector in the U.S. healthcare industry.
With inconsistent rules and regulations and the proliferation of online and retail CBD products, trusted and credible information remains hard to come by.
When researching how exactly CBD can help fight breast cancer, I was struck to learn that the bulk of scientific papers published and referenced are by authors from outside the U.S.
Buzzworthy resources include:
Dr. David Bearman, Co-founder, of the American Academy of Cannabinoid Medicine, cannabis advocate and author whose latest book "Cannabis Medicine: A Guide to the Practice of Cannabinoid Medicine" educates medical professionals on the science of the endocannabinoid system in the human body.
"One goal of the American Academy of Cannabinoid Medicine is to marginalize those doctors like the doc in Venice Beach who has the gal in the bikini out front saying a medical marijuana evaluation is $39.95. Cannabis is a real medicine. It deserves more respect than that," explained Dr. Bearman.
Also pioneering the mainstream use of cannabis in healthcare is Stacy Shymansky, Founder & CEO, of Medicine Women Consulting, an integrative health care company that combines cutting-edge alternative therapies with powerful new healing protocols, including Cannabinoid Therapy, Meridian Energy Analysis (MEA), and Plant-Based Enzyme Treatments. Dr. Bearman serves as Medicine Women's Director of Medicine.
The University of San Diego recently launched an online cannabis Healthcare and Medicine Certificate program. The program’s Co-Founder and CEO, Dr. Jessica Knox, MD, MBA, MPH is a board-certified preventative medicine physician who received her bachelor’s degree from Harvard University before going on to earn her medical and business degrees from Tufts University. After completing her residency in preventive medicine, Dr. Knox began her study of the endocannabinoid system, and is recognized as an expert in the t fields of Endocannabinology™ and cannabinoid medicine. Dr. Knox believes that all-natural medicine, including cannabis, "a natural medicine," should be the first-line approach in medical care.
An end to cannabis prohibition and its restrictive hold on medical cannabis research will unleash the power of our US intellect, science and technology to exhaust ALL possible sources to treat and defeat cancer.
In 1981 my mother was first diagnosed with breast cancer, which ultimately took her life. Like cannabis, “early detection,” let alone “breasts,” were topics not discussed.